Stable isotope-labeled compounds are used as environmental pollutant standards for the detection of air, water, soil, sediment and food.
In addition to treating various diseases, isotopes are used for imaging, diagnosis, and newborn screening.
Small molecule compounds labeled with stable isotopes can be used as chemical reference for chemical identification, qualitative, quantitative, detection, etc. Various types of NMR solvents can be used to study the structure, reaction mechanism and reaction kinetics of compounds.
Stable isotope labeling allows researchers to study metabolic pathways in vivo in a safe manner.
Isotope labeled impurities have become vital in pharmaceutical research and development providing valuable information on drug substance purity, which ensures complete safety of drugs. As a professional pharmaceutical compound service provider, BOC Sciences has rich experience in synthesizing and analyzing isotope labeled impurities. We provide labeled impurities standards of high quality and low price to all companies or institutions with R&D needs or quality control. We offer stock or custom labeled impurities standards that can be used as internal standards. All products come with comprehensive analytical data files and are of high chemical purity. In addition, we also provide custom isotope labeling service for various types of impurities. You can directly provide the impurity compounds to be labeled, or you can request the type of isotope to be labeled, the labeling site, and the isotope enrichment.
Impurities are undesired chemical constituents in active pharmaceutical ingredients or pharmaceutical formulations. Impurities have no therapeutic effect and may affect the stability and efficacy of the drug or affect the scientific management of the drug. Some impurities even have toxic side effects and damage human health. Impurities in drugs may come from various links such as drug production, storage, and sales. Impurities come from various sources and typically include starting materials, intermediates, by-products, degradation products, and the like. The existence of impurities not only affects the quality of drugs, but also reflects the problems existing in the process of production, storage and transportation. Therefore, impurity research is an important part of drug research and development.
Impurities, as a general term, are undesirable because of their harmful effects. But at the same time they do play an important role in pharmaceutical research.
In drug development, production, transportation, storage, etc., it is necessary to maintain the purity of the active ingredients of the drug, reduce the impurity content of the drug, and maximize the effectiveness and safety of the drug. Impurities standards can be used for the identification, inspection and content determination of impurities and related substances. The use of impurities standards brings time and cost savings to drug development. Isotope-labeled impurities standards contain one or more isotopic atoms in their molecules. Except for isotopic effects, the chemical properties of isotopically substituted impurities standards are generally unchanged. Thus, labeled impurities standards can participate in similar chemical reactions and are traceable.
BOC Sciences offers comprehensive isotope labeling services tailored to the specific needs of our clients. Our services include:
Choosing the right isotope label depends on the specific requirements of the study. Factors to consider include:
We mainly offer the following stable isotope labeling types.
For more types of impurities and isotopic labeling, please contact us directly.
Impurities are any substances within a drug product that are not the intended active pharmaceutical ingredient (API) or an excipient. They can arise during various stages of the drug production process.
Examples of impurities include process-related by-products, degradation products, residual solvents, and inorganic contaminants like residual metals or reagents.
The FDA sets specific limits for impurities based on the type of impurity and the dosage of the drug product. These limits are detailed in guidelines such as the International Council for Harmonisation (ICH) Q3A and Q3B.
Impurities are identified using advanced analytical techniques such as mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, high-performance liquid chromatography (HPLC), and gas chromatography (GC).
Isotope labeling is important for tracing and quantifying impurities in pharmaceutical products. It provides detailed insights into the presence, behavior, and impact of impurities, aiding in quality control and regulatory compliance.
Isotopic labeling involves the incorporation of isotopic atoms into the molecular structure of the compound of interest. This can be achieved through chemical synthesis or biosynthetic methods, followed by rigorous purification and characterization to ensure the desired isotopic composition.
Interested in our Service & Products?
Need detailed information?